The pathogenesis of mesothelioma

被引:278
作者
Carbone, M
Kratzke, RA
Testa, JR
机构
[1] Loyola Univ, Canc Immunol Program, Cardinal Bernardin Canc Ctr, Dept Pathol, Maywood, IL 60153 USA
[2] Vet Affairs Med Ctr, Dept Med, Sect Hematol & Oncol, Minneapolis, MN 55417 USA
[3] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
关键词
D O I
10.1053/sonc.2002.30227
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
About 80% of malignant mesotheliomas (MM) in the Western World develop in individuals with higher than background exposure to asbestos. Only a fraction of those exposed to asbestos develop mesothelioma, indicating that additional factors play a role. Simian virus 40 (SV40), a DNA tumor virus that preferentially causes mesothelioma in hamsters, has been detected in several human mesotheliomas. The expression of the SV40 large tumor antigen in mesothelioma cells, and not in nearby stromal cells, and the capacity of antisense T-antigen treatment to arrest mesothelioma cell growth in vitro suggest that SV40 contributes to tumor development. The capacity of T-antigen to bind and inhibit cellular p53 and retinoblastoma (Rb)-family proteins in mesothelioma, together with the very high susceptibility of human mesothelial cells to SV40-mediated transformation in vitro, supports a causative role of SV40 in the pathogenesis of mesothelioma. Asbestos appears to increase SV40-mediated transformation of human mesothelial cells in vitro, suggesting that asbestos and SV40 may be cocarcinogens. p53 mutations are rarely found in mesothelioma; p16, p14ARF, and NF2 mutations/losses are frequent. Recent studies revealed the existence of a genetic factor that predisposes affected individuals to mesothelioma in the villages of Karain and Tuzkoy, in Anatolia, Turkey. Erionite, a type of zeolite, may be a cofactor in these same villages, where 50% of deaths are caused by mesothelioma. Mesothelioma appears to have a complex etiology in which environmental carcinogens (asbestos and erionite), ionizing radiation, viruses, and genetic factors act alone or in concert to cause malignancy. Copyright © 2002 by W.B. Saunders Company.
引用
收藏
页码:2 / 17
页数:16
相关论文
共 82 条
[1]   Cellular transformation by SV40 large T antigen: interaction with host proteins [J].
Ali, SH ;
DeCaprio, JA .
SEMINARS IN CANCER BIOLOGY, 2001, 11 (01) :15-22
[2]   Familial pleural malignant mesothelioma: clustering in three sisters and one cousin [J].
Ascoli, V ;
Scalzo, CC ;
Bruno, C ;
Facciolo, F ;
Lopergolo, M ;
Granone, P ;
Nardi, F .
CANCER LETTERS, 1998, 130 (1-2) :203-207
[3]   PLEURAL MALIGNANT MESOTHELIOMA FOLLOWING WILMS-TUMOR [J].
AUSTIN, MB ;
FECHNER, RE ;
ROGGLI, VL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 86 (02) :227-230
[4]  
Baris Bahadir, 1996, Journal of Environmental Pathology Toxicology and Oncology, V15, P183
[5]   OUTBREAK OF PLEURAL MESOTHELIOMA AND CHRONIC FIBROSING PLEURISY IN VILLAGE OF KARAIN-URGUP IN ANATOLIA [J].
BARIS, YI ;
SAHIN, AA ;
OZESMI, M ;
KERSE, I ;
OZEN, E ;
KOLACAN, B ;
ALTINORS, M ;
GOKTEPELI, A .
THORAX, 1978, 33 (02) :181-192
[6]  
BARIS YI, 1987, ASBESTOS ERIONITE RE, P3
[7]  
BATTIFORA H, 1995, ATLAS TUMOR PATHOL, P17
[8]   HIGH-FREQUENCY OF INACTIVATING MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-2 GENE (NF2) IN PRIMARY MALIGNANT MESOTHELIOMAS [J].
BIANCHI, AB ;
MITSUNAGA, SI ;
CHENG, JQ ;
KLEIN, WM ;
JHANWAR, SC ;
SEIZINGER, B ;
KLEY, N ;
KLEINSZANTO, AJP ;
TESTA, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :10854-10858
[9]   Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity [J].
Bocchetta, M ;
Di Resta, I ;
Powers, A ;
Fresco, R ;
Tosolini, A ;
Testa, JR ;
Pass, HI ;
Rizzo, P ;
Carbone, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :10214-10219
[10]   Black spots concentrate oncogenic asbestos fibers in the parietal pleura - Thoracoscopic and mineralogic study [J].
Boutin, C ;
Dumortier, P ;
Rey, F ;
Viallat, JR ;
DEVuyst, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (01) :444-449